Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

H Prudden, Sharon L. Achilles, Celina Schocken, Nathalie Broutet, Karen Canfell, Hiroki Akaba, Partha Basu, Neerja Bhatla, Zvavahera M. Chirenje, Sinéad Delany‐Moretlwe, Lynette Denny, Deepa G. Gamage, Rolando Herrero, Raymond Hutubessy, Luisa L. Villa, Raúl Murillo, John T. Schiller, Margaret Stanley, Marleen Temmerman, Fanghui Zhao, Gina Ogilvie, David C. Kaslow, Peter Dull, Sami L. Gottlieb